Managing pain can be a puzzle after breast cancer

September 11, 2017

(HealthDay)—Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report.

Use of such as OxyContin (oxycodone) and Vicoprofen (hydrocodone) was "significantly associated" with failure to adhere to the hormone therapy and a higher risk of death, the study found.

"It's not a big secret that the U.S. uses more opioids than any other country in the world," said researcher Rajesh Balkrishnan, of the University of Virginia School of Medicine's department of public health sciences.

"Clearly there has to be better management of opioids in the elderly population," Balkrishnan said in a university news release.

For the study, researchers analyzed follow-through rates for adjuvant endocrine therapy—commonly called hormone treatment—among more than 10,000 women treated for . This treatment is used to prevent the cancer from returning.

The patients' average age was 72. Those who were younger, single, suffered from depression or had more advanced disease were more likely to take prescription opioids, the investigators found.

Painkillers were more often prescribed for women who had chemotherapy and than those receiving radiation therapy. The researchers speculated that newer, less painful targeted radiation therapy could help explain this finding.

The study doesn't show a causal relationship, however, and use itself may not be the reason patients don't follow through with their hormonal therapy, the researchers noted. The hormonal treatment, which is taken for up to 10 years, is associated with many unpleasant side effects, causing many women to discontinue the .

"The main problem is that these hormonal medications have so many side effects that women do not want to take them," said researcher Dr. Leslie Blackhall, a pain management expert at UVA Health System.

"They can cause really severe joint and muscle pain in a significant number of women. These women switch from one agent to the other but still can't tolerate them. They are then given opioids for the pain, which may or may not help," Blackhall explained.

More research is needed to determine if opioid use itself increases death rates among . Up to 60 percent of these patients suffer from chronic pain related to treatment, and many need powerful painkillers. However, because they are highly addictive, there is mounting pressure on doctors to limit opioid prescriptions, the study authors noted.

"A lot of doctors feel worried about prescribing them," Blackhall said.

The researchers said their findings could prompt more research and discussion on pain management among .

The study results were published in the journal Breast Cancer Research and Treatment.

Explore further: Breast cancer patients on opioids less likely to stick to vital treatment

More information: The U.S. National Institute on Drug Abuse provides more on opioids.

Related Stories

Breast cancer patients on opioids less likely to stick to vital treatment

September 1, 2017
A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.

When is an opioid safe to take?

June 26, 2017
(HealthDay)—Many people in pain are apprehensive about taking an opioid painkiller to ease their suffering, and rightfully so.

Doctors play key role keeping women breast cancer-free longer

July 27, 2017
Researchers from The University of Western Australia believe General Practitioners can play an important role in ensuring women persist with cancer treatment.

Day-supply of opioid Rx factor in likelihood of long-term use

August 24, 2017
(HealthDay)—The days supplied is far more important than the dosage level or even the type of pain being treated in risk of opioid use disorder following opioid prescription, according to a study published recently in The ...

Opioid dependence can start in just a few days

March 16, 2017
(HealthDay)—Doctors who limit the supply of opioids they prescribe to three days or less may help patients avoid the dangers of dependence and addiction, a new study suggests.

Worse pain outcomes after knee replacement for patients who took opioids before surgery

May 18, 2017
Six months after knee replacement surgery, pain outcomes were not as good for patients who previously took prescription opioids, according to a study in the May 17 issue of The Journal of Bone & Joint Surgery.

Recommended for you

Researchers create a drug to extend the lives of men with prostate cancer

March 16, 2018
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.

Improved capture of cancer cells in blood could help track disease

March 15, 2018
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer - even though most free-floating cancer cells will not go on to establish a new tumor.

Area surrounding a tumor impacts how breast cancer cells grow

March 14, 2018
Cancer is typically thought of as a tumor that needs to be removed or an area that needs to be treated with radiation or chemotherapy. As a physicist and cancer researcher, Joe Gray, Ph.D., thinks differently.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.